Dyne is a biotechnology company that develops and commercializes therapeutics for the treatment of genetic diseases. Dyne Therapeutics was founded in 2017. Dyne Therapeutics' headquarters is located in Waltham, Massachusetts, USA 02451.
Dyne Therapeu... Dyne Therapeutics's President & CEO, Joshua Brumm, currently has an approval
rating of 90%. Dyne Therapeutics's primary competitors are Avidity Biosciences, Sarepta & Neurana.
There have been no acquisitions found related to Dyne Therapeutics
Recent investment data cannot be found related to Dyne Therapeutics